Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test PIK3CA Mutation Analysis Test by NGS is 10-14 days.

What are the prerequisites for the test PIK3CA Mutation Analysis Test by NGS

  • Specimen Type: Formalin-fixed, paraffin-embedded tissue block or unstained slides with at least 20% tumor content
  • Specimen Stability: Specimens should be shipped within 96 hours of collection
  • Specimen Storage: Specimens should be stored at room temperature
  • Rejection Criteria: Specimens with less than 20% tumor content, specimens older than 96 hours, specimens not stored properly
  • Turnaround Time: Results available in 14-21 days

What are the measure values for the test PIK3CA Mutation Analysis Test by NGS

  • Positive: Presence of PIK3CA mutation detected by NGS
  • Negative: Absence of PIK3CA mutation detected by NGS

What does this test PIK3CA Mutation Analysis Test by NGS identify?

The PIK3CA Mutation Analysis Test by NGS identifies mutations in the PIK3CA gene. This gene encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which plays a critical role in cell growth, proliferation, and survival. Mutations in the PIK3CA gene have been associated with various cancers, including breast, colorectal, and endometrial cancer.

Why is this test PIK3CA Mutation Analysis Test by NGS taken?

The PIK3CA Mutation Analysis Test by NGS is taken to identify mutations in the PIK3CA gene. This gene encodes for a protein that is involved in cell growth, proliferation, and survival. Mutations in the PIK3CA gene have been linked to various cancers, including breast, colorectal, and ovarian cancer.

By analyzing the mutations in the PIK3CA gene through Next Generation Sequencing (NGS), healthcare providers can better understand the genetic makeup of a patient's cancer. This information can help in determining the most appropriate treatment plan and predicting the prognosis of the disease.

Overall, the PIK3CA Mutation Analysis Test by NGS is crucial in personalized medicine, as it allows for targeted therapies and more precise management of cancer patients.

No FAQs available.

Customer Google Rating